Literature DB >> 18325888

Cutting edge: a naturally occurring mutation in CD1e impairs lipid antigen presentation.

Sylvie Tourne1, Blandine Maitre, Anthony Collmann, Emilie Layre, Sabrina Mariotti, François Signorino-Gelo, Caroline Loch, Jean Salamero, Martine Gilleron, Catherine Angénieux, Jean-Pierre Cazenave, Lucia Mori, Daniel Hanau, Germain Puzo, Gennaro De Libero, Henri de la Salle.   

Abstract

The human CD1a-d proteins are plasma membrane molecules involved in the presentation of lipid Ags to T cells. In contrast, CD1e is an intracellular protein present in a soluble form in late endosomes or lysosomes and is essential for the processing of complex glycolipid Ags such as hexamannosylated phosphatidyl-myo-inositol, PIM(6). CD1e is formed by the association of beta(2)-microglobulin with an alpha-chain encoded by a polymorphic gene. We report here that one variant of CD1e with a proline at position 194, encoded by allele 4, does not assist PIM(6) presentation to CD1b-restricted specific T cells. The immunological incompetence of this CD1e variant is mainly due to inefficient assembly and poor transport of this molecule to late endosomal compartments. Although the allele 4 of CD1E is not frequent in the population, our findings suggest that homozygous individuals might display an altered immune response to complex glycolipid Ags.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18325888     DOI: 10.4049/jimmunol.180.6.3642

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  10 in total

Review 1.  T cells specific for lipid antigens.

Authors:  Lucia Mori; Gennaro De Libero
Journal:  Immunol Res       Date:  2012-09       Impact factor: 2.829

Review 2.  Targeting the diverse immunological functions expressed by hepatic NKT cells.

Authors:  Caroline C Duwaerts; Stephen H Gregory
Journal:  Expert Opin Ther Targets       Date:  2011-05-13       Impact factor: 6.902

3.  CD1a and CD1d genes polymorphisms in breast, colorectal and lung cancers.

Authors:  Hossein Golmoghaddam; Abdul Mohammad Pezeshki; Abbas Ghaderi; Mehrnoosh Doroudchi
Journal:  Pathol Oncol Res       Date:  2011-01-22       Impact factor: 3.201

4.  Identification of glioblastoma immune subtypes and immune landscape based on a large cohort.

Authors:  Huiyuan Zhang; Ying Chen
Journal:  Hereditas       Date:  2021-08-19       Impact factor: 3.271

5.  Polymorphisms in CD1d affect antigen presentation and the activation of CD1d-restricted T cells.

Authors:  Michael I Zimmer; Hanh P Nguyen; Bin Wang; Honglin Xu; Angela Colmone; Kyrie Felio; Hak-Jong Choi; Ping Zhou; Maria-Luisa Alegre; Chyung-Ru Wang
Journal:  Proc Natl Acad Sci U S A       Date:  2009-01-28       Impact factor: 11.205

Review 6.  Nonclassical T cells and their antigens in tuberculosis.

Authors:  Gennaro De Libero; Amit Singhal; Marco Lepore; Lucia Mori
Journal:  Cold Spring Harb Perspect Med       Date:  2014-07-24       Impact factor: 6.915

Review 7.  The evolved functions of CD1 during infection.

Authors:  Anne Kasmar; Ildiko Van Rhijn; D Branch Moody
Journal:  Curr Opin Immunol       Date:  2009-06-21       Impact factor: 7.486

Review 8.  Exogenous control of the expression of Group I CD1 molecules competent for presentation of microbial nonpeptide antigens to human T lymphocytes.

Authors:  Angelo Aquino; Grazia Graziani; Ornella Franzese; Salvatore P Prete; Enzo Bonmassar; Laura Bonmassar; Stefania D'Atri
Journal:  Clin Dev Immunol       Date:  2011-03-22

9.  Phage display of functional αβ single-chain T-cell receptor molecules specific for CD1b:Ac₂SGL complexes from Mycobacterium tuberculosis-infected cells.

Authors:  Frank Camacho; Jim Huggett; Louise Kim; Juan F Infante; Marco Lepore; Viviana Perez; María E Sarmiento; Graham Rook; Armando Acosta
Journal:  BMC Immunol       Date:  2013-02-25       Impact factor: 3.615

Review 10.  Role of lipid transfer proteins in loading CD1 antigen-presenting molecules.

Authors:  Luc Teyton
Journal:  J Lipid Res       Date:  2018-03-19       Impact factor: 5.922

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.